Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Jonge ex-patiënten ervaren lagere kwaliteit van leven na behandeling lymfoom
mrt 2017 | Lymfoom